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ABSTRACT: The increasing popularity of “Mirto” liqueur,
produced from Myrtus communis berries, has led to the planting
of domesticated cultivars, expanding myrtle berry production. To
promote the use of cultivated berries, the content in the
nutraceutical compounds ellagitannins has been investigated
both in spontaneous and cultivated fruits. Oenothein B and
eugeniflorin D2, characterized by
1H and 13C NMR, were
isolated and quantified using ultrahigh-performance liquid
chromatography−diode array detector−tandem mass spectrom-
etry (UPLC−DAD−MS/MS). The antifungal and anti-inflam-
matory activities of oenothein B were assayed in vitro. Large
amounts of oenothein B and eugeniflorin D2 were detected in
seeds (12 ± 2.4 and 5.8 ± 1.2 mg/g). The oenothein B
concentration in liqueurs was 194 ± 22 mg/L. This macrocyclic ellagitannin dimer showed anti-Candida (minimal inhibitory
concentration <8−64 μg/mL) and anti-inflammatory properties. Cultivated myrtle berries are a source of nutraceutical
compounds. The high concentration of oenothein B in liqueur suggests a possible contribution to the organoleptic and
biological properties of the beverage.
1. INTRODUCTION
Myrtus communis L. is an evergreen shrub or small tree growing
spontaneously in the Mediterranean basin, Madeira, and West
Asia.1 In Sardinia (Italy), myrtle berries are largely employed
in the food industry, principally by the liqueur industry to
produce the popular “Mirto di Sardegna”, recognized as a
geographical indication of the island of Sardinia, according to
EC Reg. no. 110/2008. Annual production of Mirto di
Sardegna is ca. 2 million bottles. With the scope of protecting
production, given its economic importance in the Sardinian
agricultural sector, manufacturing specifications have been
established since 1998 on the basis of an in-depth study of the
chemical composition of the berry and the production process
for the liqueur.2 The berries used to produce the liqueur must
be gathered without the use of pesticides or fertilizers and
picked in Sardinia, and no flavoring agents, colorants, and
preservatives should be added.
The popularity of the liqueur suggested a need for
agronomical research to domesticate spontaneous plants, and
the result was the planting of about 200 ha of myrtle plants in
Sardinia.3 Unfortunately, liqueur producers prefer fruit from
wild plants, which are available in sufficient quantities;
therefore, the market demand for products made with
nonspontaneous plants is poor. For this reason, there is a
strong interest in seeking applications in fields other than the
liqueur industry. Better knowledge of the nutraceutical
properties of myrtle berries might represent an incentive for
their future exploitation in the food, pharmaceutical, and
cosmetic industries.
M. communis L. berries are rich in phenolic compounds,
including phenolic acids (gallic acid, ellagic acid), flavonols
(myricetin glycosides with small quantities of quercetin and
kaempferol glycosides), flavan-3-ols (epigallocatechin, epigal-
locatechin 3-O-gallate (EGCG), and epicatechin 3-O-gallate),
and anthocyanins.2,4,5 The distinctive tannic and astringent
taste of myrtle berry hydroalcoholic extract cannot be
explained by the limited presence of proanthocyanidins,
whose content ranges from 93 to 503 mg/L in liqueur.2
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Although the phytochemical profile of myrtle berries has
previously been described, the ellagitannin (ET) content in
berries and liqueur has been little investigated. Ellagitannins
(ETs) are a complex class of bioactive compounds, with
distribution restricted to dicotyledonous angiosperms.6 From a
chemical point of view, ETs are a complex class of hydrolysable
tannins, characterized by the presence of one or more
hexahydroxydiphenoyl units, generally esterified to a glucopyr-
anose group. Their presence has been detected in edible fruits
of plants belonging to the orders Fagales, Rosales, and
Myrtales, such as walnut, strawberry, raspberry, pomegranate,
and myrtle (Myrtus communis L.).6,7 Consumption of food
containing ETs has been associated with improved health and
reduced chronic pathologies such as inflammatory, cardiovas-
cular, and neurodegenerative diseases and cancer,8−10 and,
thus they are classified as potential nutraceutical ingredients.11
The biological activities of ETs are related to two principal
properties: their antioxidant potential,12 involved in the
prevention and delayed development of carcinogenesis, and
their ability to participate in the complexation of macro-
molecules, thus defending against inflammation and other
gastrointestinal disorders such as infections caused by
microorganisms.11,13 Due to the important properties of ETs
for human health described above and to promote the use of
myrtle berries, we investigated their presence in fruits collected
from both cultivated and wild plants. We focused in particular
on the chemical and biological properties of myrtle seeds.
The aim of the first part of this study was (i) to isolate and
structurally characterize the main ETs present in myrtle berries
and (ii) to quantify their presence in M. communis L. picked
from different locations in Sardinia. We compared the
composition of domesticated cultivars and wild plants to
evaluate the possibility of promoting the nutraceutical
properties of cultivated fruits.
The aim of the second part of the study was the investigation
of (iii) the antifungal and (iv) the anti-inflammatory properties
of oenothein B, the most abundant ET found and isolated from
M. communis L. berries.
2. RESULTS AND DISCUSSION
2.1. Berry Composition. Myrtle berries are round fruits,
composed of a fleshy pericarp and a snail-shaped seed. We
investigated the composition of 38 samples obtained from both
cultivated (23) and wild (15) plants to estimate the relative
mass of seeds and pericarp tissues. Seeds represented on
average 22.3% of the fruit, while the rest of the weight was
represented by fleshy tissues, as shown in Table 1. A slight
difference, albeit not significant (p > 0.05), was observed in
berries obtained from cultivated and wild plants.
2.2. Ellagic Acid and Ellagitannins from Myrtle Seeds.
Myrtle fruit is rich in secondary metabolites. The seeds in
particular have previously been reported to contain a larger
amount of phenolic compounds in comparison with other
tissues in the pericarp.4,14,15 Ellagic acid is released after
hydrolysis of ellagitannins, and its presence in myrtle berries is
well documented.14,16 We investigated its content in seeds and
found that the average amount of EA was 0.49 ± 0.14 mg/g,
both for wild and cultivated samples (Table 2). No significant
differences (p > 0.05) were observed between cultivated and
wild plants.
Two main dimeric ellagitannins, eugeniflorin D2 (1) and
oenothein B (2), with a specific macrocyclic structure were
isolated from seed extracts and chemically characterized.
Eugeniflorin D2 was first isolated from Eugenia uniflora, a
plant belonging to the Myrtaceae family shown to have
digestive properties.21 Oenothein B was found in Oenothera
erythrosepala18 and subsequently detected in other species
belonging to the Myrtales order. Interestingly, eugeniflorin D2
can be converted into oenothein B when kept in aqueous
solution at 80 °C for 1 day.17 The presence of eugeniflorin D2
and oenothein B in myrtle berries was investigated. Chemical
analysis revealed that the compounds are accumulated in all
parts of the fruit, but the amount was particularly high in seeds
(Table 2). Here, eugeniflorin D2 and oenothein B were found
in average quantities of 5.8 ± 1.2 and 12 ± 2.4 mg/g,
respectively, while in pulp and peel extract the concentrations
were 1.7 ± 0.1 and 1.8 ± 0.1 mg/g, respectively (data not
shown). Thus, in M. communis L. berries, seeds represent the
main reservoir for both ellagitannins.
Table 1. Berry Compositiona
sample (no. of specimens) berries (g) pericarp (g) seeds (g) % seeds
Year 2008−2009
cultivated (12) 10.4 ± 0.51 8.5 ± 0.24 2.0 ± 0.23 19.0 ± 0.53
wild (6) 10.4 ± 0.23 8.5 ± 0.35 2.1 ± 0.56 24.9 ± 1.55
Year 2010−2011
cultivated (11) 10.4 ± 0.34 8.5 ± 0.53 1.9 ± 0.75 22.6 ± 1.12
wild (11) 10.3 ± 0.65 8.0 ± 0.24 2.3 ± 0.43 28.9 ± 0.84
Year 2013−2014
cultivated (16) 10.0 ± 0.46 8.0 ± 0.49 2.0 ± 0.42 24.5 ± 2.34
wild (12) 10.0 ± 0.53 7.9 ± 0.34 2.0 ± 0.15 25.8 ± 1.45
aData are mean ± standard deviation from three independent experiments.
Table 2. Ellagic Acid and Ellagitannins in Myrtle Berry
Seedsa
samples (no. of
specimens) ellagic acid
eugeniflorin
D2 oenothein B
Year 2008−2009
cultivated (12) 0.48 ± 0.09 5.35 ± 2.10 13.61 ± 2.20
wild (6) 0.55 ± 0.15 5.14 ± 1.80 11.03 ± 1.13
Year 2010−2011
cultivated (11) 0.33 ± 0.09 4.91 ± 0.76 10.84 ± 2.50
wild (11) 0.40 ± 0.15 5.32 ± 1.23 10.55 ± 3.07
Year 2013−2014
cultivated (16) 0.65 ± 0.17 7.75 ± 1.65 15.15 ± 2.25
wild (12) 0.56 ± 0.21 6.54 ± 0.91 13.60 ± 1.23
aData are expressed as mg/g dry weight and are mean ± standard
deviation from three independent experiments.
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No significant differences were observed in wild and
cultivated samples (p > 0.05). In myrtle, eugeniflorin D2 and
oenothein B have previously been detected in leaves;19
however, to the best of our knowledge, there are no reports
relating to berries in the literature.
2.3. Oenothein B Content in Mirto di Sardegna
Liqueur. We also investigated the content of the eugeniflorin
D2 and oenothein B in Mirto di Sardegna liqueur. No traces of
eugeniflorin D2 were detected, while the average amount of
oenothein B in liqueur samples obtained from the three main
Sardinian producers was 194 ± 22 mg/L. According to our
analysis of berry composition, the estimated amount of fresh
berries used (up to a maximum of approx. 180 g/L) is even
higher than the legal minimum (150 g/L) prescribed by the
production protocol. Our analysis therefore contributed
toward highlighting the quality of Sardinian Mirto liqueur.
The presence of oenothein B in liqueurs at a concentration
of 124 μM, which is well above the taste threshold
concentrations for the astringent sensation of similar taste-
active ETs in aqueous solution (pH = 4.5), in the range of
0.2−6.3 μM,20 is thought to contribute toward explaining the
slightly tannic, astringent taste of the liqueur. Moreover, recent
studies have proven that astringency is a trigeminal perception
in humans and have reported the existence of a trigeminal G
protein-coupled receptor specific for galloylated molecules.20
This study described the dose−response curves for the
activation of isolated mouse trigeminal ganglion cells by
several phenolic plant astringents, indicating that galloyl
moieties are necessary for strongly activating substances.
Oenothein B has two valoneoyl and galloyl moieties each in
its structure (Figure 4).
Finally, it has been shown that ETs can activate human
bitter taste receptors,21 with all ETs investigated in this library
of polyphenols found to be capable of interacting with the
bitter receptor TAS2R7, with the half-maximal activation
agonist concentration (EC50) being in the range of 2.43−7.26
μM. In conclusion, oenothein B has all of the structural
requirements to be taste-active and we suggest that it could
explain the liqueur’s particular oral sensation. Further work is
needed to precisely evaluate the contribution of oenothein B to
astringency and bitterness in the specific matrix.
Oenothein B has been shown to have anticancer, anti-
inflammatory, antioxidant, and antimicrobial properties.22 Due
to the documented biological properties, it is reasonable to
believe that oenothein B might contribute to the beneficial
effect of berry-derived products and liqueur on human health.
Seed extracts have a positive effect on the treatment of
oesophagitis-induced reflux and colitis in rats, exhibiting anti-
inflammatory properties.23 Myrtle liqueur also has vasodilatory
properties,24 and extracts obtained from myrtle berries have
been shown to exert antibacterial activity against food-borne
pathogens and to have an ulcer-protective effect.25,26
2.4. Oenothein B Shows Antifungal Activity against
Fluconazole-Sensitive and -Resistant Candida Strains.
Oenothein B was subjected to further studies to assess its
biological properties and the possible beneficial effects deriving
from the consumption of foods containing this metabolite.
Oenothein B was able to inhibit the growth of all of the
Candida strains tested, in a concentration-dependent manner
(Figure 1), with MIC50 values ranging from <8 to 64 μg/mL
(Table 3). The inhibitory properties of the molecule against
fluconazole-resistant strains of Candida albicans, Candida
tropicalis, and Candida glabrata are worth noting.
As previously reported, oenothein B is active against the
pathogen Paracoccidioides brasiliense, which is the causal agent
of the most prevalent human systemic mycosis in Latin
America.27 Through analysis of the transcription profile of
Figure 1. Oenothein B inhibits the growth of C. glabrata (strain RTT199_3) in a dose-dependent manner. C. glabrata was treated with increasing
concentrations of oenothein B for 65 h. The cells were allowed to grow in dark conditions, at 37 °C, and with continuous shaking. The growth
curves were recorded using a spectrophotometer (530 nm). The graph shows the geometric means of three independent experiments.
Table 3. Anti-Candida Activity of Oenothein B from Myrtle
Seedsa
MIC range (μg/mL)
strain (no.) oenothein B fluconazole
C. albicans (3) <8−64 0.125 to >64
C. glabrata (2) 8−64 0.125 to >64
C. parapsilosis (1) 32 0.125
C. tropicalis (1) <8 >64
aData are geometric mean of the MIC50 values measured for each
strain in three independent experiments.
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fungi treated with oenothein B, it has been found that the
compound exerts its antifungal activity by inhibiting the
transcription of genes like 1,3-β-glucan synthase (PbFKS1),
GLN1, and KRE6, which are involved in cell wall biosyn-
thesis.27 The human gut is commonly colonized by Candida
spp., but alteration of the normal gastrointestinal flora
(dysbiosis), often associated with the use of antibiotics,
physical and psychological stress, hormone intake, and dietary
changes, can increase levels of Candida colonization, which is
associated with several diseases of the gastrointestinal tract,
inflammation, and delays in the healing of inflammatory
lesions. Moreover, the gut is considered to be a source for yeast
dissemination and systemic candidiasis development, which is
associated with high rates of morbidity and mortality in
immunocompromised patients.28 Considering that agents able
to reduce the levels of barrier alteration and inhibit the growth
of Candida species inhabiting the gastrointestinal tract are
important for control of the dissemination and development of
candidiasis, consumption of new products obtained from
myrtle berries and containing oenothein B could exert a
beneficial effect on controlling proliferation of Candida spp. in
the human gut during episodes of dysbiosis.
2.5. Oenothein B Inhibits IL-8 Release in TNFα- or IL-
1β-Treated AGS Cells through Inhibition of NF-κB
Signaling. The stomach is one of the first sites of action of
bioactive molecules consumed with the diet, and ETs have
already shown anti-inflammatory activity at the gastric level,
both in vitro and in vivo.9,10 Helicobacter pylori is the main
etiological agent of gastritis. This bacterium can establish a
persistent infection in the gastric mucosa, and the local
production of chemokines represents an important step in the
recruitment and activation of inflammatory cells. The chemo-
kine IL-8 plays a pivotal role during H. pylori infection by
promoting neutrophil infiltration, and gastric epithelial cells are
among the main producers of this chemokine in gastric
mucosa.29 IL-8 mucosal or serum levels have been positively
associated with gastric inflammation, even in the absence of H.
pylori.29,30 Furthermore, H. pylori strains, associated with
peptic ulceration, induce a higher level of IL-8 in vitro31 and
increased IL-8 production has been correlated with more
severe grades of gastritis. This chemokine is regulated at the
transcriptional level by the transcription factors NF-κB and
AP-1, and its secretion by gastric epithelial cells is induced by
H. pylori or cytokines such as TNFα and IL-1β.32 To test the
inhibitory activity of oenothein B on IL-8 secretion, human
gastric epithelial AGS cells were treated with TNFα (10 ng/
mL) or IL-1β (10 ng/mL) in the presence of increasing
concentrations of the ellagitannin (0.25−10 μM) for 6 h.
In both conditions, the pure compound inhibited IL-8
release in a concentration-dependent fashion (Figure 2, panels
A, B), with low IC50 (0.54 and 1.29 μM for IL-8 release
induced by TNFα or IL-1β, respectively). Since IL-8 release is
NF-κB-dependent, we investigated whether oenothein B could
impair the NF-κB pathway in AGS cells. Oenothein B inhibited
the NF-κB-driven transcription induced by TNFα or IL-1β in a
concentration-dependent manner, with IC50 1.34 and 2.01 μM,
respectively (Figure 3, panels A, B). To confirm the effect of
the pure compound on the NF-κB pathway, cells were treated
with TNFα or IL-1β in the presence of increasing
concentrations of oenothein B for 1 h, and the amount of
p65 in the nuclear fraction was measured with enzyme-linked
immunosorbent assay (ELISA) and normalized using the
protein content. The compound inhibited nuclear trans-
location induced by both cytokines with a similar profile
(IC50 1.18 and 2.72 μM, following induction with TNFα or IL-
1β, respectively), thus confirming that inhibition of IL-8
release was due, at least in part, to impairment of the NF-κB
pathway (Figure 3, panels C, D).
None of the concentrations used in the assays (0.25−25
μM) showed signs of cytotoxicity in the 3,4,5-dimethylthiazol-
2-yl-2,5-diphenyltetrazolium bromide (MTT) assay after 6 h of
treatment.
The results obtained in our cell model clearly show that
oenothein B significantly attenuates the release of IL-8 by
gastric epithelial cells acting on the NF-κB pathway. Previous
in vitro studies have shown that ETs are fairly stable in the
physiological conditions of the stomach: gastric pH and
digestive enzymes are not able to hydrolyze or modify ETs and
they are not absorbed in this area,33 suggesting possible action
directly in situ. Moreover, oenothein B showed an anti-H.
pylori effect on four different strains, thus increasing the
interest in this pure ET as a potential antigastritis compound.34
This is the first time that oenothein B has been shown to
have anti-inflammatory properties at the gastric level,
supporting the beneficial effects attributed to the consumption
of food enriched with ETs in the gastrointestinal tract.
3. CONCLUSIONS
ET-rich foods are very promising ingredients in the human
diet. Here, we have provided further evidence on the additional
health effects of native myrtle berry ETs. Myrtle berries, and
the seeds in particular, have been found to contain high
amounts of the valuable ETs eugeniflorin D2 and oenothein B,
Figure 2. Oenothein B inhibits IL-8 release induced by TNF-α or IL-
1β in AGS cells. To test the effect on IL-8 secretion, AGS cells were
treated with 10 ng/mL TNF-α (panel A) or IL-1β (panel B) in the
presence of increasing concentrations of oenothein B for 6 h. The
amount of released IL-8 was measured using the ELISA assay. The
graphs show the means ± standard deviation (sd) of at least three
experiments. Treatment with the reference compound (20 μM
EGCG) reduced the secretion by 70 and 36% for TNF-α and IL-1β,
respectively. Statistical analysis: one-way analysis of variance
(ANOVA), followed by Bonferroni as the post hoc test. *p < 0.05,
***p < 0.0001 versus stimulus alone.
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and no differences were detected between wild and cultivated
fruits. As the main ellagitannin detected, oenothein B was
subjected to further studies to assess its biological properties.
Here, we showed that it is able to inhibit the growth of several
sensitive and fluconazole-resistant Candida species inhabiting
the gastric tract, encouraging further investigations that could
lead to the discovery of broader antifungal action and thus to
characterization of a new antifungal compound. In addition,
oenothein B was not only toxic for human cell lines but also
showed growth inhibition properties against H. pylori35 and
anti-inflammatory activity in human gastric epithelial cells,
suggesting that it may represent a possible support in the
antigastritis therapy.
Taken together, our findings underline the value of M.
communis L. seeds, without discriminating between samples
obtained from cultivated or wild sources. They are a rich
source of a valuable metabolite whose properties could be
exploited by the food and pharmaceutical industries for the
development of products useful for human health, taking
advantage of the benefits derived from ellagitannin-enriched
food consumption on the intestinal tract.
4. EXPERIMENTAL SECTION
4.1. General Section. 4.1.1. Solvents. Methanol and
acetone were of HPLC grade, acetonitrile was of LC−MS
grade, and all were purchased from Sigma-Aldrich (St. Louis,
MO). Formic acid 98−100% was also purchased from Sigma-
Aldrich. Milli-Q water was used for chromatography.
4.1.2. Apparatus. For chemical analysis, a ultrahigh-
performance liquid chromatography−diode array detector−
tandem mass spectrometry (UPLC−DAD−MS/MS, Waters
Xevo TQ) apparatus equipped with an ACQUITY UPLC
HSST3 column (1.8 μm, 2.1 × 100 mm2) was used.
Compound isolation was performed on a Waters HPLC
equipped with a 2695 sample manager, 2996 PDA (Milford,
MA), and a Supelco Discovery HS C18 column (10 mm × 250
mm, 10 μm). NMR analysis were performed using a Bruker
Avance 400 MHz NMR spectrometer. Mass spectrometry was
performed using a LTQ Orbitrap XL Hybrid Ion Trap-
Orbitrap mass spectrometer (Thermo Fisher, Waltham, MA)
equipped with an electrospray ion source (ESI).
4.2. Plant Material. Berries from cultivated Myrtus
communis L. plants belonging to the Angela, Maria Rita,
Rosella, Maria Elisa, Erika, Uta, Comune, Piccola, LAC11, and
Michela Bianco cultivars were obtained from several farmers,
while those from wild plants were collected at several locations
on the island of Sardinia in the winters of 2008−2009, 2010−
2011, and 2013−2014, as reported in Table 1. For each
sample, a stock of berries was frozen soon after picking and
kept at −20 °C till use, while another stock was weighed to
register the whole mass and then crushed gently to manually
separate the seeds from the pericarp to determine the relative
mass. The analysis was performed in triplicate. One-way
analysis of variance (ANOVA) followed by Bonferroni as a
post hoc test was applied. Differences in p-values of <0.05 were
considered to be statistically significant.
4.3. Mirto di Sardegna Liqueur. The samples of Mirto di
Sardegna liqueur, collected from three producers, were
prepared in compliance with the product specifications
reported in the Decree of June 8, 2016, published in Italian
Official Journal no. 139 of June 16, 2016. In short, the
production requires an infusion of ripe, freshly collected
berries, in stainless steel tanks, for at least 15 days, with an
hydroalcoholic solution (≥40% vol). The infusion is then
extracted, and demineralized water can be added to the berries
for a second extraction. The berries are then pressed to recover
the liquid. The two infusions and the press fraction are then
pooled and filtered for the preparation of the liqueur. The
liqueur is prepared by mixing the infusion with alcohol and a
syrup made of water and sugar, and optionally honey (less than
15% of the sugar). Addition of antioxidants, colorants,
preservatives, and other spirits is not allowed. Bottling can
only occur in glass containers, and the final alcohol content is
adjusted to a value between 28 and 36% vol. The minimum
quantity of berries is 150 g/L in the final liqueur.
4.4. Compound Isolation. Aliquots of berries obtained
from the M. communis L. cultivars listed above were mixed in
equal amounts, and seeds were collected from a total of 1.2 kg
of fresh berries. Seeds (ca. 270 g) were manually separated
from the pericarp, washed under tap water, and then ground
under liquid nitrogen using a laboratory mill to obtain a fine
powder. The powder was defatted with hexane and then
subjected to extraction with a solution of 70% acetone in water
(1:10 w/v). The solid seed biomass was separated from the
raw extract by centrifugation for 15 min at 4000g and 5 °C,
and the extraction solution was evaporated in a rotary
evaporator. The extract was suspended in 100 mL of methanol
before injection in semipreparative high-performance liquid
chromatography (HPLC).
Compound isolation was performed using a Waters HPLC
equipped with a 2695 sample manager, 2996 PDA (Milford,
Figure 3. Oenothein B inhibits NF-κB-driven transcription and
nuclear translocation induced by TNF-α or IL-1β in AGS cells. AGS
cells were transiently transfected with the NF-κB-LUC plasmid and
then treated with increasing concentrations of oenothein B in the
presence of TNF-α (panel A) or IL-1β (panel B). Treatment with the
reference compound (20 μM EGCG) reduced transcription by 85 and
64% for TNF-α and IL-1β, respectively. The amount of p65 in the
nuclear fraction following treatment with oenothein B in the presence
of the proinflammatory stimuli for 1 h was also assessed (panels C and
D). Treatment with the reference compound (20 μM EGCG)
reduced translocation by 90 and 64% for TNF-α and IL-1β,
respectively. The graphs show the means ± sd of at least three
experiments. Statistical analysis: one-way analysis of variance
(ANOVA), followed by Bonferroni as the post hoc test. *p < 0.05,
**p < 0.01, ***p < 0.0001 versus stimulus alone.
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MA), and a Supelco Discovery HS C18 column (10 mm × 250
mm, 10 μm). Mobile phases were composed of Milli-Q water
(A) and acetonitrile containing 0.1% formic acid (B). The
column temperature was set to 50 °C, the injection volume
was 100 μL, and the flow rate was 1 mL/min. After an initial 6
min for equilibration, the gradient conditions were as follows:
0−1 min, 0% B; 1−5 min, 0−10% B; 5−10 min, 10−25% B;
10−20 min, 25−100% B; and 20−22 min 100% B.
Fractions containing the target compounds (retention range
2.8−3.6 min for compound 1 and 4−5.1 min for compound 2)
were collected with an automatic collector based on UV
detection and the HPLC−UV chromatogram recorded at 270
nm. Fractions containing the single compounds were
combined, the solvent was removed by rotary evaporation,
and the residue was suspended in water and frozen at −20 °C.
The samples were then lyophilized and prepared for nuclear
magnetic resonance (NMR) measurements and mass spec-
trometry analysis.
4.5. NMR and Mass Spectrometry Experiments. 1H
(400 MHz) and 13C (100 MHz) NMR spectra for the purified
ETs were recorded in acetone-d6 and D2O (only data for D2O
are reported here) at 298 K using a 5 mm BBI probe with 90°
proton pulse length of 8.7 μs at a transmission power of 0 db
and equipped with pulsed gradient field utility. The chemical
shift scale (δ) was calibrated on the residual proton signal of
deuterated acetone at δH 2.040 and δC 29.80 and on the
residual proton signals of deuterated water at δH 4.78. The
following NMR experiments were carried out: 1H NMR;
decoupled 13C NMR; 1H−1H correlation spectroscopy;
1H−13C heteronuclear single quantum coherence; and
1H−13C heteronuclear multiple bond correlation.
For the mass spectrometry measurement, negative ion
analysis was performed in data-dependent analysis mode.
The ESI conditions in negative mode are as follows: spray
voltage, −3.5 kV; heated capillary temperature, 320 °C;
capillary voltage, −35 V; and tube lens, −110 V. In the LTQ
component of the instrument, nitrogen was used as both the
sheath gas (35 U) and auxiliary gas (5 U), and helium was
used as the damping gas. All measurements were made using
the automatic gain control of LTQ to adjust the number of
ions entering the trap. Mass calibration was performed with
every sequence run just prior to starting the batch, using the
flow injection of the manufacturer’s calibration standard
mixture, allowing for mass accuracy lower than 5 ppm in
external calibration mode. Full-scan accurate mass spectra were
obtained at a mass resolution of 30 000 FWHM (m/z 400) in
profile mode, while the resolving power for MS2 scans was
7500. Product ions were generated in the LTQ trap at a
collision energy of 35 eV using an isolation width of 1 Da.
4.5.1. Compound 1. According to NMR and HRMS data,
compound 1 was identified as eugeniflorin D2 (Figure 4):
1H
NMR (400 MHz, deuterium oxide) δ 7.16 (s, galloyl-I G, 2H),
7.15 (d, J = 2 Hz, dehydrovaloneoyl, 1H), 7.09 (s, galloyl-II′,
2H), 6.80 (s, valoneoyl, 1H), 6.77 (s, valoneoyl, 1H), 6.58 (s,
valoneoyl, 1H), 6.49 (s, valoneoyl, 1H), 6.04 (s, valoneoyl,
1H), 6.05 (d, J = 2.4 Hz, H1-αglucose, 1H), 5.73 (t, J = 9.8 Hz,
H3-αglucose, 1H), 5.57 (dd, J = 2.4, 9.8 Hz, H2-αglucose,
1H), 5.49 (brs, dehydrovaloneoyl, 1H), 5.28 (t, J = 9.8 Hz,
H2-βglucose), 5.25 (dd, J = 13.5, 6.0 Hz, H6-αglucose, 1H),
5.22 (t, J = 9.8 Hz, H3-βglucose, 1H), 4.96 (t, J = 9.8 Hz, H4-
βglucose, 1H), 4.93 (dd, J = 14.1, 5.8 Hz, H6- βglucose, 1H),
4.78 (d, 8.0, H1-βglucose, 1H), 4.66 (t, J = 8.0 Hz, H4-
βglucose, 1H), 4.57 (dd, J = 6.5, 9.8, H5-αglucose, 1H), 4.47
(t, J = 9.8, H4-αglucose, 1H), 4.25 (dd, J = 9.8, 6.4 Hz, H5-
βglucose, 1H), 3.97 (d, J = 13.5 Hz, H6-αglucose, 1H), 3.79
(d, J = 14.1 Hz, H6-βglucose, 1H). Through 1H NMR signal
integration, the purity of eugeniflorin D2 was estimated to be
around 90%.
HRMS data for compound 1: ESI(−)MS: [M − H]−
1583.1383 ± 0.008, calculated for C68H47O45
−: 1583.1395;
[M − 2H − H2O]2− 782.0604 ± 0.004, calculated for
C68H44O44
2−: 782.0608.
4.5.2. Compound 2. According to NMR and HRMS data,
compound 2 was identified as oenothein B (Figure 4).
NMR data of compound 2: 1H NMR (400 MHz, deuterium
oxide) δ 7.16 (s, ring G, 2H), 6.86 (s, ring G′, 2H), 6.78 (s,
ring C′, 1H), 6.69 (s, ring B, 1H), 6.58 (s, ring A′, 1H), 6.51
(s, ring C, 1H), 6.49 (s, ring B′, 1H), 6.44 (s, ring A, 1H), 5.82
(t, J = 10.3 Hz, H3-αglucose, 1H), 5.60 (d, J = 3.0 Hz, H1-
αglucose, 1H), 5.55 (t, J = 9.0 Hz, H4α-glucose, 1H), 5.47 (t, J
= 9.0 Hz, H3-βglucose), 5.30 (dd, J = 13.5, 6.0 Hz, H6-
αglucose, 1H), 5.22 (t, J = 8.7 Hz, H2-βglucose, 1H), 5.10 (t, J
= 10.1 Hz, H4-βglucose, 1H), 4.85 (dd, J = 14.1, 5.8 Hz, H6-
βglucose, 1H), 4.74 (m, H2-αglucose, 1H), 4.70 (d, J = 8.0 Hz,
H1-βglucose, 1H), 4.66 (dd, J = 9.8, 5.2 Hz, H5-αglucose,
1H), 4.19 (dd, J = 9.8, 5.2 Hz, H5-βglucose, 1H), 3.98 (d, J =
13.5 Hz, H6-βglucose, 1H), 3.95 (d, J = 14.1 Hz, H6-α-
glucose, 1H). Through 1H NMR signal integration the purity
Figure 4. Structures of eugeniflorin D2 and oenothein B.
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of oenothein B was estimated to be around 93%. 13C NMR
(100 MHz, D2O) δ 170.58 (s), 170.10 (s), 169.72 (s), 169.40
(s), 167.82 (s), 166.98 (s), 147.15 (s), 145.70 (s), 145.27 (s),
144.95 (s), 144.54 (s), 144.18 (s), 144.03 (s), 143.17 (s),
142.59 (s), 141.89 (s), 140.51 (s), 139.51 (s), 139.41 (s),
139.30 (s), 139.08 (s), 138.53 (s), 138.48 (s), 136.76 (s),
136.39 (s), 135.87 (s), 135.31 (s), 126.00 (s), 125.66 (s),
125.58 (s), 123.36 (s), 121.88 (s), 120.53 (s), 119.98 (s),
117.50 (s), 117.09 (s), 115.74 (s), 115.63 (s), 114.14 (s),
113.94 (s), 111.19 (d, 2C), 110.83 (d), 109.81 (d), 109.70 (d,
2C), 107.76 (d), 106.33 (d), 95.55 (d), 90.23 (d), 75.54 (d),
75.03 (d), 73.12 (d), 71.79 (d), 71.38 (d), 71.23 (d), 70.24
(d), 68.34 (d), 64.46 (t), 63.97 (t).
HRMS data for compound 2: [M − H]− 1567.1398 ±
0.008, calculated for C68H47O44
−: 1567.1446; [M − 2H]2−
783.0668 ± 0.004, calculated for C68H46O44
2−: 783.0686.
4.6. Sample Preparation and Chemical Analysis. Pulp,
seeds, and liqueur were subjected to chemical analysis. Samples
of pulp and seeds obtained from 10 g of fresh berries for each
sample were extracted separately with 20 mL of a solution of
acetone and water (70:30 v/v). Traces of the solvent were
removed using a rotary evaporator, and the extract was
suspended in a 20 mL solution of methanol and water (50/50)
before chemical analysis. Samples of three commercial Mirto di
Sardegna liqueurs were mixed with an equal volume of a 50%
methanol solution and stored at −20 °C before chemical
analysis via ultrahigh-performance liquid chromatography−
diode array detection−tandem mass spectrometry (UPLC−
DAD−MS/MS).
Extracts were analyzed according to the method described
by Vrhovsek et al.36 for the presence of ellagic acid and
oenothein B using a UPLC−DAD−MS/MS (Waters Xevo
TQ) apparatus equipped with an ACQUITY UPLC HSST3
column (1.8 μm, 2.1 × 100 mm2) and separation was carried
out at 40 °C. The mobile phase was composed of eluent A
(0.1% formic acid in water) and eluent B (0.1% formic acid in
acetonitrile). Acetonitrile of LC−MS grade and pure standard
of ellagic acid (HPLC grade) were purchased from Sigma-
Aldrich (St. Louis, MO), while oenothein B was isolated as
reported above. Milli-Q water was used for chromatography.
The flow rate was set to 0.4 mL/min, and the gradient
profile was the following: 0 min 5% B, from 0 to 3 min linear
gradient to 20% B, 80% A; from 3 to 5 min, linear gradient to
95% B; isocratic elution from 5 to 7 min and from 7 to 10 min
and re-equilibration to the initial conditions of 5% B. The
injection volume was 2 μL for both sample and standard
solutions. Each sample was analyzed in triplicate. After each
injection, the needle was rinsed with 600 μL of a weak washing
solution (water/methanol, 90:10) and 200 μL of a strong
washing solution (methanol/water, 90:10). Samples were kept
at 6 °C during the analysis. The DAD spectrum was recorded
between 200 and 600 nm. Mass spectrometry detection was
performed on a Waters Xevo TQMS (Milford, MA)
instrument equipped with an electrospray (ESI) source.
Capillary voltage was 3.5 kV in positive mode and −2.5 kV
in negative mode; the source was kept at 150 °C; the
desolvation temperature was 500 °C; the cone gas flow was 50
L/h; and the desolvation gas flow was 800 L/h.
Each metabolite was directly infused in the MS system in
negative mode with 50:50 v/v of two mobile phases A and B to
optimize the detection process. The two most abundant
fragments were selected for each metabolite, one as a quantifier
(most abundant) and the other as a qualifier ion using the
multiple reaction monitoring (MRM) method for selective
quantification. The MRM conditions were optimized automati-
cally by Waters Intellistart software. MRM transitions for
ellagic acid, eugeniflorin D2, and oenothein B are reported in
Table 4.
For the quantification, linear calibration curves were
obtained by the injection of 10 dilutions of the stock solution
in a concentration range of 0.178−670 mg/L for oenothein B
and 0.130−208 mg/L for eugeniflorin D2. The calibration
curve of ellagic acid was obtained by the injection of eight
dilutions of the stock solution in a concentration range of
0.056−180 mg/L. All standard solutions were prepared in
water. Data processing, calibration curve calculation, and
quantification were carried out by Waters TargetLynx software.
All curves showed good linearity over the concentration range.
The limit of detection (LOD) for onothein B was 0.059 mg/L,
and the limit of quantification (LOQ) was 0.244 mg/L. For
eugeniflorin D2, the LOD was calculated to be 0.064 mg/L and
the LOQ was 0.190 mg/L, while for ellagic acid, the LOD was
0.028 mg/L and the LOQ was 0.095 mg/L.
4.7. Antifungal Susceptibility Assay. For antifungal
susceptibility testing, clinical strains isolated from human gut
C. albicans MFB005FS3, C. albicans MFB008MM1, C. albicans
YMS 102_2, C. parapsilosis MFB005FS5, C. glabrata MFB004,
C. glabrata MFB005FS4, C. glabrata RTT99_3, and C.
tropicalis RTT037-337 were tested for their susceptibility to
oenothein B.
Yeasts were grown on Sabouraud agar medium (Sigma-
Aldrich, St. Louis, MO) for 48 h at 30 °C and resuspended in
distilled water at a concentration of (1−5) × 105 CFU/mL
before testing.
Yeasts were tested for their susceptibility to oenothein B
(five dilution series, ranging from 125 to 8 μg/mL) following
the European Committee for Antimicrobial Susceptibility
Testing protocol.38 Briefly, cells were grown in RPMI-1640
medium supplied with 2.0% glucose, counted, and inoculated
at a concentration of (1−5) × 105 CFU/mL. Minimal
inhibitory concentration (MIC) values were determined
using a spectrophotometer (at 530 nm) after 48 and 120 h
of incubation as the lowest concentration of the drug that
resulted in a ≥50% inhibition of growth relative to the growth
control.
Growth curves for oenothein-treated and untreated Candida
spp. were recorded using a spectrophotometer (at 530 nm).
Inoculated plates were kept in the dark at 37 °C, with gentle
agitation, and the cell density values were measured every 30
min for over 65 h.
4.8. Anti-inflammatory Assay. Human adenocarcinoma
epithelial gastric cells (AGS, CRL-1739, LGC Standard S.r.l.,
Table 4. UPLC−ESI−MS/MS Conditions for Quantification and Identification of Metabolites
metabolite rt (min) ESI mode cone voltage MRM transitions quantifier ion MRM transitions qualifier ion supplier
acid ellagic 4.03 + 32 302.91 → 257.2 (26) 302.91 → 201.1 (32) Sigma-Aldrich
eugeniflorin D2 1.63 − 34 1582.8 → 935.2 (40) 1582.8 → 831.0 (37) isolation
onothein B 2.54 − 38 1576.2 → 765.2 (42) 503.41 → 937.2 (44) isolation
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Milan, Italy) were grown at 37 °C in DMEM F12 (Gibco-
Invitrogen) supplemented with 100 U penicillin/mL, 100 mg
of streptomycin/mL, 2 mM L-glutamine, and 10% heat-
inactivated fetal calf serum (FCS) (Euroclone S.p.A, Pero,
Italy) in a humidified atmosphere containing 5% CO2. During
treatments with oenothein B or vehicle alone (<0.1% dimethyl
sulfoxide), cells were placed in a medium deprived of FCS.
To test IL-8 release, AGS cells were grown in 24-well plates
(30 000 cells/well) for 48 h; then, cells were treated with the
proinflammatory stimuli TNFα or IL-1β (10 ng/mL) in the
presence of oenothein B. IL-8 release reached its maximum at
6 h, and this time was selected for experiments to test the effect
of the individual compound (0.25−10 μM). After 6 h, the
medium was collected and stored at −20 °C until IL-8
quantification with an enzyme-linked immunosorbent assay
(ELISA) kit (Peprotech, Rocky Hill, NJ), as previously
described.17 These assays were performed in duplicate, and
at least three experiments were performed.
To evaluate the effect on NF-κB-driven transcription, cells
were plated in 24-well plates (30 000 cells/well). After 48 h,
cells were transiently transfected using the calcium-phosphate
method with the reporter plasmids NF-κB-LUC (50 ng/well),
which contain the luciferase gene, under the control of three
κB-responsive elements. The plasmid was a gift from Dr. N.
Marx (Department of Internal medicine, Cardiology, Uni-
versity of Ulm, Germany). After 16 h, cells were stimulated
with TNFα or IL-1β (10 ng/mL) and pure ellagitannin was
tested at 0.5−25 μM. After 6 h, cells were lysed and luciferase
assay was performed using BritelitePlus reagent (PerkinElmer
Inc., Massachusetts), according to the manufacturer’s
instructions; the signal was read with VictorX3 (PerkinElmer,
Walthman MA). Data were expressed considering 100% of
luciferase activity related to cytokine-induced NF-κB-driven
transcription. These assays were performed in triplicate within
each experiment, and at least three experiments were
performed.
To assess the effects of oenothein B on NF-κB (p65) nuclear
translocation, AGS cells were plated at a density of 1.5 × 106
cells/mL in 100 mm plates. After 48 h, cells were treated for 1
h with TNFα or IL-1β (10 ng/mL) and oenothein B (1−10
μM). Nuclear extracts were prepared using the nuclear
extraction kit from the Cayman Chemical Company
(Michigan), and stored at −80 °C until assay. The same
amount of total nuclear proteins (10 μg/well), measured
according to the Bradford (Bio-Rad) assay, was used to assess
NF-κB nuclear translocation using the NF-κB (p65) tran-
scription factor assay kit (Cayman) followed by spectroscopy
at 450 nm, 0.1 s (VictorX3, PerkinElmer, Walthman MA).
Data were expressed considering 100% of absorbance related
to cytokine-induced NF-κB nuclear translocation. These assays
were performed in duplicate within each experiment. At least
three experiments were performed. Epigallocatechin 3-O-
gallate (EGCG) 20 μM was used as the reference compound
for each inflammation-related test.
4.9. Cytotoxicity. The cytotoxicity of oenothein B was
evaluated with the 3,4,5-dimethylthiazol-2-yl-2-5-diphenylte-
trazolium bromide (MTT) assay, as previously described.39
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Dietary polyphenols and the prevention of diseases. Crit. Rev. Food Sci.
Nutr. 2005, 45, 287−306.
(9) Sangiovanni, E.; Vrhovsek, U.; Rossoni, G.; Colombo, E.;
Brunelli, C.; Brembati, L.; Trivulzio, S.; Gasperotti, M.; Mattivi, F.;
Bosisio, E.; Dell’Agli, M. Ellagitannins from Rubus berries for the
control of gastric inflammation: in vitro and in vivo studies. PLoS One
2013, 8, No. e71762.
(10) Fumagalli, M.; Sangiovanni, E.; Vrhovsek, U.; Piazza, S.;
Colombo, E.; Gasperotti, M.; Mattivi, F.; De Fabiani, E.; Dell’Agli, M.
Strawberry tannins inhibit IL-8 secretion in a cell model of gastric
inflammation. Pharmacol. Res. 2016, 111, 703−712.
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